Evoke Pharma, Inc. Soared
Mon, Nov 18, 2019 at 05:30 PM
Evoke Pharma, Inc. (EVOK:NASDAQ) rocketted today at $1.48, representing a gain of 34.5%. On Fri, 15 Nov 19, EVOK:NASDAQ hit a New 2-Week High of $1.1. The stock featured on our News Catalysts scanner on Wed, 13 Nov 19 at 09:23 AM. From Mon, 28 Oct 19, the stock recorded 64.29% Up Days and 46.67% Green Days
About Evoke Pharma, Inc. (EVOK:NASDAQ)
Evoke Pharma Inc is a specialty pharmaceutical company which focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. It is engaged in developing an investigational metoclopramide nasal spray called Gimoti.
Top 10 Gainers:
- Karuna Therapeutics, Inc. (KRTX:NASDAQ), 442.99%
- Hermitage Offshore Services Ltd. (PSV:NYSE), 55.14%
- Evoke Pharma, Inc. (EVOK:NASDAQ), 34.55%
- Protalix BioTherapeutics, Inc. (PLX:NYSEMKT), 32.31%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 29.78%
- BiomX Inc. (PHGE:NYSEMKT), 29.2%
- Standard Diversified Inc. (SDI:NYSEMKT), 27.64%
- Advaxis, Inc. (ADXS:NASDAQ), 26.57%
- Waitr Holdings Inc. (WTRH:NASDAQ), 26.28%
- Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ), 26.1%